4//SEC Filing
MCNAY JOSEPH C 4
Accession 0000914190-19-000004
CIK 0000707511other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:40 PM ET
Size
15.4 KB
Accession
0000914190-19-000004
Insider Transaction Report
Form 4
MCNAY JOSEPH C
Director
Transactions
- Conversion
Convertible Promissory Note (right to buy)
2019-01-06−522,280→ 0 totalExercise: $0.06From: 2014-01-07Exp: 2019-01-06→ Common Stock (522,280 underlying) - Conversion
Common Stock
2019-01-06$0.06/sh+522,280$31,337→ 6,524,122 total
Holdings
- 120,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2021-03-25→ Common Stock (120,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $0.36Exp: 2022-06-30→ Common Stock (100,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2028-07-17→ Common Stock (200,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $0.19Exp: 2022-02-11→ Common Stock (100,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $0.64Exp: 2023-03-16→ Common Stock (100,000 underlying) - 125,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2027-09-01→ Common Stock (125,000 underlying)
Footnotes (5)
- [F1]The Convertible Promissory Note in the principal amount of $25,000 accrued $6,336.81 in interest and both principal and interest were converted into 522,280 shares of common stock at a conversion price of $0.06 per share.
- [F2]100% vested.
- [F3]25,000 shares vest on each of 3/16/16, 3/16/17, 3/16/18 and 3/16/19.
- [F4]31,250 shares vest on each of 9/1/17, 9/1/18, 9/1/19 and 9/1/20.
- [F5]50,000 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
Documents
Issuer
REGENERX BIOPHARMACEUTICALS INC
CIK 0000707511
Entity typeother
Related Parties
1- filerCIK 0001257674
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:40 PM ET
- Size
- 15.4 KB